1. Home
  2. FBIO vs VCIG Comparison

FBIO vs VCIG Comparison

Compare FBIO & VCIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FBIO
  • VCIG
  • Stock Information
  • Founded
  • FBIO 2006
  • VCIG 2013
  • Country
  • FBIO United States
  • VCIG Malaysia
  • Employees
  • FBIO N/A
  • VCIG N/A
  • Industry
  • FBIO Biotechnology: Pharmaceutical Preparations
  • VCIG Diversified Commercial Services
  • Sector
  • FBIO Health Care
  • VCIG Consumer Discretionary
  • Exchange
  • FBIO Nasdaq
  • VCIG Nasdaq
  • Market Cap
  • FBIO 34.1M
  • VCIG 34.7M
  • IPO Year
  • FBIO N/A
  • VCIG 2023
  • Fundamental
  • Price
  • FBIO $2.04
  • VCIG $0.52
  • Analyst Decision
  • FBIO Strong Buy
  • VCIG
  • Analyst Count
  • FBIO 3
  • VCIG 0
  • Target Price
  • FBIO $12.50
  • VCIG N/A
  • AVG Volume (30 Days)
  • FBIO 211.0K
  • VCIG 608.0K
  • Earning Date
  • FBIO 08-12-2024
  • VCIG 08-06-2024
  • Dividend Yield
  • FBIO N/A
  • VCIG N/A
  • EPS Growth
  • FBIO N/A
  • VCIG 61.67
  • EPS
  • FBIO N/A
  • VCIG 0.21
  • Revenue
  • FBIO $85,114,000.00
  • VCIG $19,781,731.00
  • Revenue This Year
  • FBIO N/A
  • VCIG N/A
  • Revenue Next Year
  • FBIO $70.41
  • VCIG N/A
  • P/E Ratio
  • FBIO N/A
  • VCIG $2.66
  • Revenue Growth
  • FBIO 32.48
  • VCIG 91.25
  • 52 Week Low
  • FBIO $1.24
  • VCIG $0.50
  • 52 Week High
  • FBIO $10.35
  • VCIG $9.35
  • Technical
  • Relative Strength Index (RSI)
  • FBIO 53.93
  • VCIG 47.44
  • Support Level
  • FBIO N/A
  • VCIG N/A
  • Resistance Level
  • FBIO $2.03
  • VCIG $0.57
  • Average True Range (ATR)
  • FBIO 0.09
  • VCIG 0.03
  • MACD
  • FBIO -0.04
  • VCIG -0.01
  • Stochastic Oscillator
  • FBIO 99.51
  • VCIG 82.54

About FBIO Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.

About VCIG VCI Global Limited

VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development solution consultancy. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology Consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment which focuses on listing solutions, investor relations, and boardroom strategies consultancy. It has established a diverse local and international clientele, providing them with its services in both local and cross-border listings. Its role begins with pre-listing diagnosis and planning to the finalization of the entire listing process.

Share on Social Networks: